Finance And Related Services Tenders

Open House Discount Contracts 2024-07

Openhouse Procedure Various Active Pharmaceutical Ingredients from October 1St, 2024

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion Within the Framework of the So-Called Open House Procedure.

Open House Biologics Discount Agreements 2024-03 - Omalizumab

Open House Contracts for Several Active Ingredients/Combinations of Active Ingredients

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V (Open House Model)

Open House Biologics Discount Agreements 2024-02 - Romiplostim

Q3 4 Multi-Jet Impeller Domestic Water Meter

Open Framework Agreement on Drug Discounts in Accordance with Section 130A Paragraph 8 Sgb V with the Possibility of Joining at any Time, So-Called Approval Model 2023-07

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Medicines with the Active Ingredient Lacosamide (Atc Code: N03ax18).